• Product nameAnti-KALRN antibody
    See all KALRN primary antibodies
  • Description
    Rabbit polyclonal to KALRN
  • Tested applicationsSuitable for: Functional Studies, ELISA, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Horse, Chicken, Cow, Dog
  • Immunogen

    Synthetic peptide:


    conjugated to KLH, corresponding to amino acids 1591-1605 of Human KALRN (NP_001019831.2).

  • Positive control
    • Human skeletal muscle tissue.



Our Abpromise guarantee covers the use of ab115235 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Functional Studies Use a concentration of 10 µg/ml. (agonist)
ELISA 1/1 - 1/1000.
IHC-P Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.


  • FunctionPromotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity.
  • Tissue specificityIsoform 2 is brain specific. Highly expressed in cerebral cortex, putamen, amygdala, hippocampus and caudate nucleus. Weakly expressed in brain stem and cerebellum. Isoform 4 is expressed in skeletal muscle.
  • Involvement in diseaseGenetic variation in KALRN is associated with susceptibility to coronary heart disease type 5 (CHDS5) [MIM:608901]. CHD is the leading cause of death and disability worldwide. CHD is multifactorial disease with a strong genetic component. Classic epidemiologic studies have revealed many risk factors for CHD, including age, sex, hypertension, dyslipidemia, diabetes mellitus, smoking, and physical inactivity.
  • Sequence similaritiesBelongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.
    Contains 1 CRAL-TRIO domain.
    Contains 2 DH (DBL-homology) domains.
    Contains 1 fibronectin type-III domain.
    Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
    Contains 2 PH domains.
    Contains 1 protein kinase domain.
    Contains 2 SH3 domains.
    Contains 5 spectrin repeats.
  • DomainThe two GEF domains catalyze nucleotide exchange for RAC1 and RhoA which are bound by DH1 and DH2 respectively. The two GEF domains appear to play differing roles in neuronal development and axonal outgrowth. SH3 1 binds to the first GEF domain inhibiting GEF activity only when in the presence of a PXXP peptide, suggesting that the SH3 domain/peptide interaction mediates binding to GEF1. CRK1 SH3 domain binds to and inhibits GEF1 activity.
  • Post-translational
  • Cellular localizationCytoplasm. Cytoplasm > cytoskeleton. Associated with the cytoskeleton.
  • Information by UniProt
  • Database links
  • Alternative names
    • Duo antibody
    • FLJ16443 antibody
    • HAPIP antibody
    • Huntingtin associated protein interacting protein (duo) antibody
    • Huntingtin-associated protein-interacting protein antibody
    • Kalirin (isoform 2) antibody
    • Kalirin antibody
    • KALRN antibody
    • KALRN_HUMAN antibody
    • Protein Duo antibody
    • RhoGEF kinase antibody
    • Serine/threonine kinase with Dbl and pleckstrin homology domains antibody
    • Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain antibody
    • TRAD antibody
    see all

Anti-KALRN antibody images

  • Human skeletal muscle tissue (formalin-fixed, paraffin-embedded) stained with ab115235 at 5 ug/ml followed by biotinylated goat anti-rabbit IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.

References for Anti-KALRN antibody (ab115235)

ab115235 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab115235.
Please use the links above to contact us or submit feedback about this product.